The balance sheet, income statement and cash flow statement of a company listed in Borsa Istanbul is given below. Market price of a share in Borsa Istanbul is 15 TL. According to the information below calculate Mcap, enterprise value, net financial debt, Ebitda, net debt/Ebitda, current ratio, quick ratio, cash ratio, financial leverage, net working capital, interest coverage ratio, book value per share, earnings per share on 2021/3rd quarter in TL. Write a short comment about the ratios that you calculated. (maximum 5-10 sentences) ASSETS CURRENT ASSETS Cash and Cash Equivalents Note (Unaudited) Current Period 30 September 2021 USD'000 (Unaudited) Current Period 30 September 2021 TRY'000 (Audited) (Audited) Previous Period Previous Period 31 December 2020 USD'000 31 December 2020 TRY'000 4.522.945 40.156.967 3.883.556 28.507.242 Financial Investments Trade Receivables 1.463.675 1.094 777.824 12.995.238 1.844.858 13.542.177 9.714 6.905.911 5.320 Due From Related Parties 18.998 168.671 521.467 35.282 39.048 3.827.829 258.985 Other Trade Receivables from Third Parties 758.826 6.737.240 486.185 3.568.844 Other Receivables 5.880 52.211 6.338 46.520 Due From Related Parties 589 5.231 1.484 10.892 Other Receivables from Third Parties 5.291 46.980 4.854 35.628 Financial Derivative Instruments 30.065 266.935 5.110 37.510 Inventories Prepaid Expenses 2.089.344 18.550.243 1.376.838 10.106.678 Prepaid Expenses to Related Parties Other Prepaid Expenses to Third Parties Other Current Assets 29.538 1.301 28.237 125.525 262.251 11.550 250.701 1.114.464 18.117 38 132.990 280 18.079 105.508 132.710 774.490 NON CURRENT ASSETS 4.506.069 40.007.133 4.016.984 29.486.670 Financial Investments 37 328 27 199 Other Receivables 6.200 55.045 5.357 39.325 Due From Related Parties 3 3.527 31.317 3.877 28.458 Other Receivables from Third Parties 2.673 23.728 1.480 10.867 Financial Derivative Instruments 11 94 Investments Accounted for Using Equity Method 5 30.978 Investment Properties Property, Plant and Equipment Right of Use Assets Intangible Assets 49.489 3.732.648 48.078 295.380 275.041 439.390 33.140.315 426.860 2.622.532 31.327 229.956 50.156 368.168 3.550.417 26.061.836 43.273 55.952 317.644 410.715 Goodwill 126.620 1.124.194 Other Intangible Assets 6 168.760 1.498.338 55.952 410.715 Prepaid Expenses 295.073 2.619.808 241.956 1.776.075 Prepaid Expenses to Related Parties 3 91.050 Other Prepaid Expenses to Third Parties 204.023 Deferred Tax Assets 12 Other Non Current Assets 16.692 31.483 808.388 1.811.420 148.199 279.521 87.646 643.367 154.310 1.132.708 9.851 28.668 72.311 210.441 TOTAL ASSETS 9.029.014 80.164.100 7,900.540 57.993.912 (Unaudited) Current Period 30 September (Unaudited) Current Period 30 September (Audited) (Audited) Previous Period Previous Period 31 December 31 December 2021 2021 LIABILITIES CURRENT LIABILITIES Note USD'000 TRY'000 2020 USD'000 2020 TRY'000 1.720.310 15.301.302 1.285.214 9.434.112 Short Term Borrowings 8 436.113 3.879.004 162.591 1.193.496 Short Term Portion of Long Term Borrowings 8 294.354 2.618.132 353.114 2.592.032 Trade Payables 546.218 4.858.333 513.173 3.766.949 Due to Related Parties 3 13.538 120.410 17.892 131.336 Other Trade Payables to Third Parties 532.680 4.737.923 495.281 3.635.613 Payables for Employee Benefits 10 25.705 228.632 26.878 197.296 Other Payables 18.649 165.875 17.967 131.885 Financial Derivative Instruments 37.544 333.939 8.117 59.582 Deferred Revenue Current Tax Liabilities Short Term Provisions Other Current Liabilities Long Term Borrowings 108.253 962.860 73.863 542.194 12 211.759 1.883.489 73.117 536.715 9 30.772 273.706 34.551 253.624 10.943 97.332 21.843 160.339 NON CURRENT LIABILITIES 1.241.295 11.040.696 1.013.313 7.438.224 8 525.227 4.671.628 383.181 2.812.743 Long Term Provisions 139.266 1.238.704 131.890 968.136 Long term provisions for employee benefits 10 139.266 1.238.704 131.890 968.136 Deferred Tax Liabilities 12 576.575 5.128.344 497.989 3.655.488 Other Non Current Liabilities 227 2.020 253 1.857 EQUITY 6.067.409 Equity Attributable to Equity Holders of the Parent 5.868.226 53.822.102 52.076.639 Share Capital 13 1.818.371 3.500.000 5.602.013 5.421.241 1.818.371 41.121.576 39.809.427 3.500.000 Inflation Adjustment to Capital 81.366 156.613 81.366 Treasury Shares (-) (60.387) (116.232) Share Issue Premium (Discounts) Other Comprehensive Income (Expenses) Not to be Reclassified to Profit (Loss) 55.303 (65.066) 106.447 (60.387) 55.303 156.613 (116.232) 106.447 17.263.191 (55.530) 13.067.766 Revaluation Reserve of Tangible Assets 10.589 Actuarial (Loss) Gain funds (59.970) 95.172 (196.395) 10.844 (50.689) 77.866 Foreign Currency Translation Reserves (15.685) 17.364.414 (15.685) (115.606) 13.105.506 Other Comprehensive Income (Expense) to be (147.003) 867.800 Reclassified to Profit (Loss) (103.971) 241.213 Foreign Currency Translation Reserves (143.056) 902.902 (101.862) 256.694 Cash Flow Hedging Gain (Loss) (3.947) (35.102) (2.109) (15.481) Restricted Reserves Assorted from Profit 1.178.392 4.628.583 1.041.255 3.597.448 Retained Earnings 1.671.421 14.866.456 2.172.478 15.947.079 Net Profit for the Period 1.335.829 10.803.781 Non-Controlling Interests 199.183 1.745.463 TOTAL LIABILITIES AND EQUITY 9.029.014 80.164.100 472.356 180.772 7.900.540 3.309.093 1.312.149 57.993.912 (Unaudited) Current Period 1 January- (Unaudited) Current Period 1 January- (Unaudited) Current Period 1 July- (Unaudited) Previous Period 1 January- (Unaudited) Previous Period 1 January- (Unaudited) Previous Period 1 July- 30 September 2021 30 September 2021 30 September 2021 30 September 2020 30 September 2020 30 September 2020 Note USD'000 TRY'000 TRY'000 USD'000 TRY'000 TRY'000 Revenue Cost of Sales GROSS PROFIT 14 5.324.172 43.060.307 18.262.741 3.264.921 21.936.023 8.152.865 14 (3.312.360) (26.789.372) (11.028.836) (2.745.302) (18.444.861) (6.727.901) 2.011.812 16.270.935 7.233.905 519.619 3.491.162 1.424.964 Marketing Expenses 15 (30.644) (247.840) (81.675) (28.574) (191.979) (65.692) General Administrative Expenses 15 (53.129) (429.693) (157.154) (51.860) (348.434) (113.885) Research and Development Expenses (3.770) (30.494) (12.586) (3.044) (20.449) (6.995) Other Operating Income 15 20.383 164.848 43.927 88.433 594.158 258.353 Other Operating Expenses 15 (15.586) (126.060) (40.790) (16.194) (108.802) (37.843) OPERATING PROFIT 1.929.066 15.601.696 6.985.627 508.380 3.415.656 1.458.902 Income from Investing Activities 1.732 14.009 5.255 23.189 155.798 148.784 Expenses from Investing Activities (1.930) (15.606) 205 (6.079) (40.844) (1.778) Share of Investments' Profit Accounted by Using The Equity Method 5 547 4.425 5.725 462 3.104 (5.673) OPERATING PROFIT BEFORE FINANCE INCOME (EXPENSES) 1.929.415 15.604.524 6.996.812 525.952 3.533.714 1.600.235 Finance Income 16 83.191 1.097.534 165.698 17.733 340.965 58.748 Finance Expense 16 (40.231) (325.373) (110.003) (55.070) (370.002) (103.268) PROFIT BEFORE TAX 1.972.375 16.376.685 7.052.507 488.615 3.504.677 1.555.715 Tax (Expense) Income 12 (579.792) (5.113.890) (1.840.180) (258.032) (1.955.455) (933.351) Current Corporate Tax (Expense) Income (526.411) (4.682.162) (1.896.705) (203.627) (1.589.921) (689.616) Deferred Tax (Expense) Income (53.381) (431.728) 56.525 (54.405) (365.534) (243.735) NET PROFIT FOR THE PERIOD 1.392.583 11.262.795 5.212.327 230.583 1.549.222 622.364 Non-Controlling Interests Equity Holders of the Parent 56.754 1.335.829 459.014 10.803.781 209.701 14.826 99.613 40.756 5.002.626 215.757 1.449.609 581.608 (Unaudited) Current Period 1 January- (Unaudited) Current Period 1 January- (Unaudited) Previous Period 1 January- 30 September 2021 30 September 2021 30 September 2020 30 (Unaudited) Previous Period 1 January- September 2020 Note USD'000 TRY'000 USD'000 TRY'000 CASH FLOWS FROM OPERATING ACTIVITIES Profit (Loss) for The Period Adjustments to Reconcile Profit (Loss) Adjustments for Depreciation and Amortisation Expenses Adjustments for Impairment Loss (Reversal of Impairment Loss) 748.905 6.027.960 743.215 5.432.084 1.392.583 11.262.795 230.583 1.549.222 656.035 6.185.308 381.905 2.782.812 6/14/15 163.931 1.325.825 156.238 1.049.722 (4.597) (37.185) 3.121 20.973 Adjustments for Provision (Reversal of Provision) for Receivables (2.998) (24.250) (260) (1.742) Adjustments for Provision (Reversal of Provision) for Inventories (1.599) (12.935) 3.148 21.152 Adjustments for Provision (Reversal of Provision) for Property, Plant and Equipment Adjustments for Provisions 233 1.563 31.076 251.337 28.582 199.223 Adjustments for Provision (Reversal of Provision) for Employee Termination Benefits Adjustments for Provision (Reversal of Provision) for Pending Claims and/or Lawsuits 10 23.949 193.703 23.682 159.108 9 7.127 57.634 4.900 40.115 Adjustments for Interest (Income) and Expenses (25.342) (204.969) (2.457) (16.506) Adjustments for Interest Income 16 (45.233) (365.837) (45.042) (302.622) Adjustments for Interest Expense 16 28.065 226.980 43.944 295.248 Deffered Financial Expense from Credit Purchases 15 1.053 7.076 Unearned Financial Income from Credit Sales (8.174) (66.112) (2.412) (16.208) Adjustments for Unrealised Foreign Exchange Differences Adjustments for Fair Value (Gains) Losses (14.539) (133.692) (40.606) (286.779) (17.216) (139.235) (4.477) (30.082) Adjustments for Fair Value (Gains) Losses on Derivative Financial Instruments Adjustments for Undistributed Profits of Investments Accounted for Using Equity Method Adjustments for Tax (Income) Expenses Adjustments for Losses (Gains) on Disposal of Non-Current Assets Adjustments for Losses (Gains) on Disposal of Property, Plant and Equipment Adjustments for Reconciliation of Profit (Loss) 759 (17.216) (139.235) (4.477) (30.082) (547) (4.425) (462) (3.104) 579.792 5.113.890 258.032 1.955.455 1.702 1.702 13.762 (15.791) (106.090) 13.762 (15.791) (106.090) (58.225) (275)